share_log

BioNTech | 6-K: Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine

SEC announcement ·  Sep 11, 2023 16:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more